Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Inhibition of Polo-like kinase 2 ameliorates pathogenesis in Alzheimer's disease model mice.

Lee JS, Lee Y, André EA, Lee KJ, Nguyen T, Feng Y, Jia N, Harris BT, Burns MP, Pak DTS.

PLoS One. 2019 Jul 15;14(7):e0219691. doi: 10.1371/journal.pone.0219691. eCollection 2019.

2.

Primum non nocere: a call for balance when reporting on CTE.

Stewart W, Allinson K, Al-Sarraj S, Bachmeier C, Barlow K, Belli A, Burns MP, Carson A, Crawford F, Dams-O'Connor K, Diaz-Arrastia R, Dixon CE, Edlow BL, Ferguson S, Fischl B, Folkerth RD, Gentleman S, Giza CC, Grady MS, Helmy A, Herceg M, Holton JL, Howell D, Hutchinson PJ, Iacono D, Iglesias JE, Ikonomovic MD, Johnson VE, Keene CD, Kofler JK, Koliatsos VE, Lee EB, Levin H, Lifshitz J, Ling H, Loane DJ, Love S, Maas AI, Marklund N, Master CL, McElvenny DM, Meaney DF, Menon DK, Montine TJ, Mouzon B, Mufson EJ, Ojo JO, Prins M, Revesz T, Ritchie CW, Smith C, Sylvester R, Tang CY, Trojanowski JQ, Urankar K, Vink R, Wellington C, Wilde EA, Wilson L, Yeates K, Smith DH.

Lancet Neurol. 2019 Mar;18(3):231-233. doi: 10.1016/S1474-4422(19)30020-1. Epub 2019 Feb 12. No abstract available. Erratum in: Lancet Neurol. 2019 Apr;18(4):e3.

3.

Traumatic Brain Injury in Mice Induces Acute Bacterial Dysbiosis Within the Fecal Microbiome.

Treangen TJ, Wagner J, Burns MP, Villapol S.

Front Immunol. 2018 Nov 27;9:2757. doi: 10.3389/fimmu.2018.02757. eCollection 2018.

4.
5.

Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury.

Main BS, Villapol S, Sloley SS, Barton DJ, Parsadanian M, Agbaegbu C, Stefos K, McCann MS, Washington PM, Rodriguez OC, Burns MP.

Mol Neurodegener. 2018 Apr 4;13(1):17. doi: 10.1186/s13024-018-0249-5.

6.

Glial- and Neuronal-Specific Expression of CCL5 mRNA in the Rat Brain.

Lanfranco MF, Mocchetti I, Burns MP, Villapol S.

Front Neuroanat. 2018 Jan 12;11:137. doi: 10.3389/fnana.2017.00137. eCollection 2017.

7.

Combination of Fluorescent in situ Hybridization (FISH) and Immunofluorescence Imaging for Detection of Cytokine Expression in Microglia/Macrophage Cells.

Fe Lanfranco M, Loane DJ, Mocchetti I, Burns MP, Villapol S.

Bio Protoc. 2017 Nov 20;7(22). pii: e2608. doi: 10.21769/BioProtoc.2608.

8.

Temporal Changes in Cortical and Hippocampal Expression of Genes Important for Brain Glucose Metabolism Following Controlled Cortical Impact Injury in Mice.

Zhou J, Burns MP, Huynh L, Villapol S, Taub DD, Saavedra JM, Blackman MR.

Front Endocrinol (Lausanne). 2017 Sep 11;8:231. doi: 10.3389/fendo.2017.00231. eCollection 2017.

9.

Enhanced Mortality to Metastatic Bladder Cancer Cell Line MB49 in Vasoactive Intestinal Peptide Gene Knockout Mice.

Mirsaidi N, Burns MP, McClain SA, Forsyth E, Li J, Dukes B, Lin D, Nahvi R, Giraldo J, Patton M, Wang P, Lin K, Miller E, Ratliff T, Hamidi S, Crist S, Takemaru KI, Szema A.

Front Endocrinol (Lausanne). 2017 Aug 7;8:162. doi: 10.3389/fendo.2017.00162. eCollection 2017.

10.

A Mouse Model of Single and Repetitive Mild Traumatic Brain Injury.

Main BS, Sloley SS, Villapol S, Zapple DN, Burns MP.

J Vis Exp. 2017 Jun 20;(124). doi: 10.3791/55713.

11.

Sexual dimorphism in the inflammatory response to traumatic brain injury.

Villapol S, Loane DJ, Burns MP.

Glia. 2017 Sep;65(9):1423-1438. doi: 10.1002/glia.23171. Epub 2017 Jun 13.

12.

Reduced cortical excitatory synapse number in APOE4 mice is associated with increased calcineurin activity.

Neustadtl AL, Winston CN, Parsadanian M, Main BS, Villapol S, Burns MP.

Neuroreport. 2017 Jul 5;28(10):618-624. doi: 10.1097/WNR.0000000000000811.

13.

NOX2 deficiency alters macrophage phenotype through an IL-10/STAT3 dependent mechanism: implications for traumatic brain injury.

Barrett JP, Henry RJ, Villapol S, Stoica BA, Kumar A, Burns MP, Faden AI, Loane DJ.

J Neuroinflammation. 2017 Mar 24;14(1):65. doi: 10.1186/s12974-017-0843-4.

14.

Tyrosine kinase inhibition reverses TDP-43 effects on synaptic protein expression, astrocytic function and amino acid dis-homeostasis.

Heyburn L, Hebron ML, Smith J, Winston C, Bechara J, Li Z, Lonskaya I, Burns MP, Harris BT, Moussa CE.

J Neurochem. 2016 Nov;139(4):610-623. doi: 10.1111/jnc.13763. Epub 2016 Sep 27.

15.

The Effect of the APOE4 Gene on Accumulation of Aβ40 After Brain Injury Cannot Be Reversed by Increasing apoE4 Protein.

Washington PM, Burns MP.

J Neuropathol Exp Neurol. 2016 Jun 12. pii: nlw049. [Epub ahead of print]

PMID:
27297672
16.

Dendritic Spine Loss and Chronic White Matter Inflammation in a Mouse Model of Highly Repetitive Head Trauma.

Winston CN, Noël A, Neustadtl A, Parsadanian M, Barton DJ, Chellappa D, Wilkins TE, Alikhani AD, Zapple DN, Villapol S, Planel E, Burns MP.

Am J Pathol. 2016 Mar;186(3):552-67. doi: 10.1016/j.ajpath.2015.11.006. Epub 2016 Feb 5.

17.

Polypathology and dementia after brain trauma: Does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy?

Washington PM, Villapol S, Burns MP.

Exp Neurol. 2016 Jan;275 Pt 3:381-388. doi: 10.1016/j.expneurol.2015.06.015. Epub 2015 Jun 16. Review.

18.

Inhibition of amyloid precursor protein secretases reduces recovery after spinal cord injury.

Pajoohesh-Ganji A, Burns MP, Pal-Ghosh S, Tadvalkar G, Hokenbury NG, Stepp MA, Faden AI.

Brain Res. 2014 Apr 29;1560:73-82. doi: 10.1016/j.brainres.2014.02.049. Epub 2014 Mar 11.

19.

"I pick you": the impact of fairness and race on infants' selection of social partners.

Burns MP, Sommerville JA.

Front Psychol. 2014 Feb 12;5:93. doi: 10.3389/fpsyg.2014.00093. eCollection 2014.

20.

Experimental traumatic brain injury induces rapid aggregation and oligomerization of amyloid-beta in an Alzheimer's disease mouse model.

Washington PM, Morffy N, Parsadanian M, Zapple DN, Burns MP.

J Neurotrauma. 2014 Jan 1;31(1):125-34. doi: 10.1089/neu.2013.3017. Epub 2013 Dec 10.

21.

Controlled cortical impact results in an extensive loss of dendritic spines that is not mediated by injury-induced amyloid-beta accumulation.

Winston CN, Chellappa D, Wilkins T, Barton DJ, Washington PM, Loane DJ, Zapple DN, Burns MP.

J Neurotrauma. 2013 Dec 1;30(23):1966-72. doi: 10.1089/neu.2013.2960. Epub 2013 Oct 12.

22.

Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex.

Rodriguez GA, Burns MP, Weeber EJ, Rebeck GW.

Learn Mem. 2013 Apr 16;20(5):256-66. doi: 10.1101/lm.030031.112.

23.

Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients.

Joseph LA, Routledge JA, Burns MP, Swindell R, Sykes AJ, Slevin NJ, Davidson SE.

J Laryngol Otol. 2013 Mar;127(3):285-94. doi: 10.1017/S0022215113000078. Epub 2013 Feb 11.

PMID:
23398854
24.

Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states.

Kumar A, Stoica BA, Sabirzhanov B, Burns MP, Faden AI, Loane DJ.

Neurobiol Aging. 2013 May;34(5):1397-411. doi: 10.1016/j.neurobiolaging.2012.11.013. Epub 2012 Dec 27.

25.

The effect of injury severity on behavior: a phenotypic study of cognitive and emotional deficits after mild, moderate, and severe controlled cortical impact injury in mice.

Washington PM, Forcelli PA, Wilkins T, Zapple DN, Parsadanian M, Burns MP.

J Neurotrauma. 2012 Sep;29(13):2283-96. doi: 10.1089/neu.2012.2456. Epub 2012 Aug 3.

26.

Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer.

Barraclough LH, Routledge JA, Farnell DJ, Burns MP, Swindell R, Livsey JE, Davidson SE.

Radiother Oncol. 2012 Jun;103(3):327-32. doi: 10.1016/j.radonc.2012.04.018. Epub 2012 May 23.

PMID:
22633812
27.

The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Olmos-Serrano JL, Corbin JG, Burns MP.

Dev Neurosci. 2011;33(5):395-403. doi: 10.1159/000332884. Epub 2011 Nov 8.

28.

Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways.

Tsuboi K, Okamoto Y, Ikematsu N, Inoue M, Shimizu Y, Uyama T, Wang J, Deutsch DG, Burns MP, Ulloa NM, Tokumura A, Ueda N.

Biochim Biophys Acta. 2011 Oct;1811(10):565-77. doi: 10.1016/j.bbalip.2011.07.009. Epub 2011 Jul 23.

PMID:
21801852
29.

Studies on the anorectic effect of N-acylphosphatidylethanolamine and phosphatidylethanolamine in mice.

Wellner N, Tsuboi K, Madsen AN, Holst B, Diep TA, Nakao M, Tokumura A, Burns MP, Deutsch DG, Ueda N, Hansen HS.

Biochim Biophys Acta. 2011 Sep;1811(9):508-12. doi: 10.1016/j.bbalip.2011.06.020. Epub 2011 Jun 23.

PMID:
21723414
30.

Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury.

Loane DJ, Washington PM, Vardanian L, Pocivavsek A, Hoe HS, Duff KE, Cernak I, Rebeck GW, Faden AI, Burns MP.

J Neurotrauma. 2011 Feb;28(2):225-36. doi: 10.1089/neu.2010.1595.

31.

Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy.

Farnell DJ, Mandall P, Anandadas C, Routledge J, Burns MP, Logue JP, Wylie JP, Swindell R, Livsey J, West CM, Davidson SE.

Radiother Oncol. 2010 Oct;97(1):136-42. doi: 10.1016/j.radonc.2010.05.011. Epub 2010 Jun 17.

PMID:
20561698
32.

Comparison of patient-reported late treatment toxicity (LENT-SOMA) with quality of life (EORTC QLQ-C30 and QLQ-H&N35) assessment after head and neck radiotherapy.

Ho KF, Farnell DJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, Davidson SE.

Radiother Oncol. 2010 Nov;97(2):270-5. doi: 10.1016/j.radonc.2010.01.017. Epub 2010 Jun 14.

PMID:
20554338
33.

Intracellular cholesterol homeostasis and amyloid precursor protein processing.

Burns MP, Rebeck GW.

Biochim Biophys Acta. 2010 Aug;1801(8):853-9. doi: 10.1016/j.bbalip.2010.03.004. Epub 2010 Mar 19. Review.

34.

24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury.

Cartagena CM, Burns MP, Rebeck GW.

Brain Res. 2010 Mar 10;1319:1-12. doi: 10.1016/j.brainres.2009.12.080. Epub 2010 Jan 4.

35.

Challenges in neurodegeneration research.

Noble W, Burns MP.

Front Psychiatry. 2010 Mar 10;1:7. doi: 10.3389/fpsyt.2010.00007. eCollection 2010. No abstract available.

36.

The cytoplasmic adaptor protein X11alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement.

Minami SS, Sung YM, Dumanis SB, Chi SH, Burns MP, Ann EJ, Suzuki T, Turner RS, Park HS, Pak DT, Rebeck GW, Hoe HS.

FASEB J. 2010 Jan;24(1):58-69. doi: 10.1096/fj.09-138123. Epub 2009 Aug 31.

37.

Parkin promotes intracellular Abeta1-42 clearance.

Burns MP, Zhang L, Rebeck GW, Querfurth HW, Moussa CE.

Hum Mol Genet. 2009 Sep 1;18(17):3206-16. doi: 10.1093/hmg/ddp258. Epub 2009 May 29.

38.

Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy.

Ho KF, Farnell DJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, Davidson SE.

Eur J Cancer. 2009 Jul;45(11):1992-8. doi: 10.1016/j.ejca.2009.04.010. Epub 2009 May 6.

PMID:
19427196
39.

Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury.

Loane DJ, Pocivavsek A, Moussa CE, Thompson R, Matsuoka Y, Faden AI, Rebeck GW, Burns MP.

Nat Med. 2009 Apr;15(4):377-9. doi: 10.1038/nm.1940. Epub 2009 Mar 15.

40.

Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase.

Pocivavsek A, Burns MP, Rebeck GW.

Glia. 2009 Mar;57(4):444-53. doi: 10.1002/glia.20772.

41.

Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain.

Cartagena CM, Ahmed F, Burns MP, Pajoohesh-Ganji A, Pak DT, Faden AI, Rebeck GW.

J Neurotrauma. 2008 Sep;25(9):1087-98. doi: 10.1089/neu.2007.0444.

42.

The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis.

Hoe HS, Cooper MJ, Burns MP, Lewis PA, van der Brug M, Chakraborty G, Cartagena CM, Pak DT, Cookson MR, Rebeck GW.

J Neurosci. 2007 Oct 3;27(40):10895-905.

43.

Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317.

Eckert GP, Vardanian L, Rebeck GW, Burns MP.

Neurosci Lett. 2007 Aug 9;423(1):47-52. Epub 2007 Jul 1.

PMID:
17662526
44.

Cholesterol independent effect of LXR agonist TO-901317 on gamma-secretase.

Czech C, Burns MP, Vardanian L, Augustin A, Jacobsen H, Baumann K, Rebeck GW.

J Neurochem. 2007 May;101(4):929-36.

45.

Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice.

Burns MP, Igbavboa U, Wang L, Wood WG, Duff K.

Neuromolecular Med. 2006;8(3):319-28.

PMID:
16775383
46.

The effects of ABCA1 on cholesterol efflux and Abeta levels in vitro and in vivo.

Burns MP, Vardanian L, Pajoohesh-Ganji A, Wang L, Cooper M, Harris DC, Duff K, Rebeck GW.

J Neurochem. 2006 Aug;98(3):792-800. Epub 2006 Jun 12.

47.

Flow-conditioned HUVECs support clustered leukocyte adhesion by coexpressing ICAM-1 and E-selectin.

Burns MP, DePaola N.

Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H194-204. Epub 2004 Aug 26.

48.

Brain on steroids resists neurodegeneration.

Burns MP, Duff K.

Nat Med. 2004 Jul;10(7):675-6. No abstract available.

PMID:
15229510
49.

Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test.

Harkin A, Connor TJ, Burns MP, Kelly JP.

Eur Neuropsychopharmacol. 2004 Aug;14(4):274-81.

PMID:
15163436
50.

Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary.

Davidson SE, Burns MP, Routledge JA, Swindell R, Bentzen SM, West CM.

Radiother Oncol. 2003 Nov;69(2):195-200.

PMID:
14643958

Supplemental Content

Loading ...
Support Center